Dentsply Sirona initiated with an Equal Weight at Wells Fargo

Wells Fargo initiated coverage of Dentsply Sirona (XRAY) with an Equal Weight rating and $20 price target The firm does not sees a “clean setup” into 2025 for Dentsply. It is hard to make a case for multiple expansion unless the company executes and the dental market improves, the analyst tells investors in a research note. Wells says Dentsply management is cautious on macro trends and notes the dental market is sensitive to economic conditions.